Glioblastoma nearly invariably recurs, generally months after the first brain tumour is surgically removed from the patient. It's as tough as the harshest
Researchers have developed a powerful immunity-boosting postoperative hydrogel treatment that could improve the outlook for patients with glioblastoma.